J.P. Turner & Co Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,583	Closed	-$319K	–	203
2015 Q2	$319K	Buy	2,583 +222	+9%	+$26.6K	0.25%	137
2015 Q1	$264K	Sell	2,361 -1,356	-36%	-$150K	0.24%	129
2014 Q4	$376K	Buy	+3,717	New	+$361K	0.36%	93

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

J.P. Turner & Co Capital Management's IBB Position: Q3 2015 in Review

J.P. Turner & Co Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2015, closing a stake of 2,583 shares — an estimated $319K sold.

J.P. Turner & Co Capital Management first reported a position in IBB in Q4 2014 and held it in 3 quarters. The position peaked at $376K in Q4 2014. 414 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

J.P. Turner & Co Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2015 after selling out during the quarter.
J.P. Turner & Co Capital Management sold 2,583 iShares Biotechnology ETF shares in Q3 2015, an estimated $319K.
J.P. Turner & Co Capital Management first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 3 quarters.
J.P. Turner & Co Capital Management's iShares Biotechnology ETF position peaked at $376K in Q4 2014.
414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.